Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)

BACKGROUND: American tegumentary leishmaniasis (ATL) is a non-lethal parasitic disease that presents with cutaneous (CL) and mucosal (ML) clinical forms. ATL treatment aims at healing the lesions and preventing the development of the late mucosal form. Systemic meglumine antimoniate (MA) therapy wit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mem Inst Oswaldo Cruz
Asıl Yazarlar: Brahim, Lucia Regina, Valete-Rosalino, Cláudia Maria, Antônio, Liliane de Fátima, Pimentel, Maria Inês Fernandes, Lyra, Marcelo Rosandiski, Paes, Luiz Eduardo de Carvalho, da Costa, Ananda Dutra, Vieira, Iracema Forni, Dias, Cristina Maria Giordano, Duque, Maria Cristina de Oliveira, Marzochi, Mauro Celio de Almeida, Schubach, Armando de Oliveira
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Instituto Oswaldo Cruz, Ministério da Saúde 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5719553/
https://ncbi.nlm.nih.gov/pubmed/29211245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/0074-02760160478
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller